Companion Diagnostics Market 2015 - Industry Forecast by Market Research Store Forecast Report

Companion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a drug with a diagnostic test is termed predictive medicine or personalized medicine. The companion diagnostic test has the ability to predict disease risk, diagnose disease, and monitor the therapeutic response. The tests enable physicians to make informed decisions on the type of drugs to use and the dosage in order to attempt to reduce the mortality rate of diseases such as cancer and neurodegenerative disorders.

Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Companion Diagnostics market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of companion diagnostic tests and associated kits provided by the vendors. It also presents the vendor landscape and a corresponding detailed analysis of key five vendors in the Global Companion Diagnostics market. The market is highly fragmented, with the presence of many small and large vendors. It includes vendors that operate across the globe and have a substantial presence in North America and the European Union. In addition, the report discusses the major drivers that influence the growth of the Global Companion Diagnostics market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.

Visit Complete Report @ http://www.marketresearchstore.com/report/global-companion-diagnostics-market-2014-2018-10761

The report, the Global Companion Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Companion Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas
- EMEA
- APAC

Key Vendors

- Abbott Laboratories
- Agilent Technologies Inc.
- bioMérieux SA
- Qiagen N.V.
- Roche Holding AG

Other Prominent Vendors

- 20/20 Genesystems Inc.
- A & G Pharmaceutical Inc.
- AccuTheranostics Inc.
- Alacris Theranostics GmbH
- AutoGenomics Inc.
- Biogenex Laboratories Inc.
- Leica Biosystems GmbH
- Life Technologies Inc.
- Luminex Corp.
- pHLOGISTIX LLC
- Spartan Bioscience Inc.
- TheraDiag S.A.
- Theranostics Health Inc.
- Ventana Medical Systems Inc.

Key Market Drivers

- Increasing Focus on Reducing the Cost of Drug Discovery and Development.
- For a full, detailed list, view our report.

Key Market Challenges

- High Cost Associated with the Development of Companion Diagnostics.
- For a full, detailed list, view our report.

Key Market Trends

- Increase in Growth Strategies among Vendors
- For a full, detailed list, view our report.

Visit For Report Sample @ http://www.marketresearchstore.com/report/global-companion-diagnostics-market-2014-2018-10761#requestSample